Trial search - ClinicalTrials.eu

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

Using 68Ga-FAPI-46 imaging to detect fibrosis in patients with inflammatory diseases such as Crohn’s disease, ulcerative colitis, systemic sclerosis, and lung fibrosis.

Recruiting

2 1 1
Investigated Diseases:
Investigated Drugs:
- (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
A study to evaluate the efficacy and safety of etrasimod arginine in children with moderately to severely active ulcerative colitis

Recruiting

2 1 1
Investigated Drugs:
- Etrasimod Arginine
A Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis

Recruiting

2 1
Investigated Diseases:
- Colitis ulcerative
Investigated Drugs:
- SPY002
+10
A study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy

Recruiting

3 1
Investigated Drugs:
- Duvakitug
+9
A study testing duvakitug for patients with moderately to severely active ulcerative colitis

Recruiting

3 1
Investigated Diseases:
- Colitis ulcerative
Investigated Drugs:
- Duvakitug
+9
Testing icotrokinra compared to placebo for adults and adolescents with moderately to severely active ulcerative colitis

Recruiting

3 1
Investigated Diseases:
- Colitis ulcerative
Investigated Drugs:
- ICOTROKINRA
+7
Study of MT-501 in patients with active Crohn’s Disease or Ulcerative Colitis: A Phase 2 safety and effectiveness trial

Recruiting

2 1
Investigated Diseases:
- Colitis ulcerative
- Crohn’s disease
+2
Study of SAR442970 to treat moderate to severe ulcerative colitis in adults

Recruiting

2 1
Investigated Diseases:
- Colitis ulcerative
Investigated Drugs:
- Sar442970
Study of risankizumab safety and effectiveness in children and teenagers aged 2-17 years with moderate to severe ulcerative colitis

Recruiting

3 1
Investigated Diseases:
- Colitis ulcerative
Investigated Drugs:
- Risankizumab
Long-term safety study of subcutaneous vedolizumab in children and adolescents with ulcerative colitis or Crohn’s disease

Recruiting

3 1 1 1
Investigated Drugs:
- Vedolizumab
+4

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes